🚀 VC round data is live in beta, check it out!
Kras, prehrambena Valuation Multiples
Discover revenue and EBITDA valuation multiples for Kras, prehrambena and similar public comparables like LASCO Manufacturing, Duncan Fox, Rokiskio Suris, Naturhouse Health and more.
Kras, prehrambena Overview
About Kras, prehrambena
Kras, prehrambena industrija DD operates in confectioner industry in Croatia. The company is engaged in the production of products like biscuits, wafers, candy, and chocolates.
Founded
1911
HQ
Employees
2.6K
Website
Sectors
Financials (FY)
EV
$194M
Kras, prehrambena Financials
Kras, prehrambena reported last fiscal year revenue of $229M and EBITDA of $19M.
In the same fiscal year, Kras, prehrambena generated $70M in gross profit, $19M in EBITDA, and $8M in net income.
Kras, prehrambena P&L
In the most recent fiscal year, Kras, prehrambena reported revenue of $229M and EBITDA of $19M.
Kras, prehrambena expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $229M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $70M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 31% | XXX | XXX | XXX |
| EBITDA | — | XXX | $19M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 8% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 9% | XXX | XXX | XXX |
| Net Profit | — | XXX | $8M | XXX | XXX | XXX |
| Net Margin | — | XXX | 3% | XXX | XXX | XXX |
| Net Debt | — | — | $18M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Kras, prehrambena Stock Performance
Kras, prehrambena has current market cap of $176M, and enterprise value of $194M.
Market Cap Evolution
Kras, prehrambena's stock price is $124.79.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $194M | $176M | -0.1% | XXX | XXX | XXX | $5.45 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialKras, prehrambena Valuation Multiples
Kras, prehrambena trades at 0.8x EV/Revenue multiple, and 10.0x EV/EBITDA.
Kras, prehrambena Financial Valuation Multiples
As of April 19, 2026, Kras, prehrambena has market cap of $176M and EV of $194M.
Equity research analysts estimate Kras, prehrambena's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Kras, prehrambena has a P/E ratio of 22.9x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $176M | XXX | $176M | XXX | XXX | XXX |
| EV (current) | $194M | XXX | $194M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 0.8x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 10.0x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 9.3x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 2.8x | XXX | XXX | XXX |
| P/E | — | XXX | 22.9x | XXX | XXX | XXX |
| EV/FCF | — | XXX | (11.2x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Kras, prehrambena Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Kras, prehrambena Margins & Growth Rates
Kras, prehrambena's revenue in the last fiscal year grew by 4%.
Kras, prehrambena's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.
Kras, prehrambena Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 4% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 8% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (19%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 22% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Kras, prehrambena Public Comps
See public comps and valuation multiples for other Food & Beverages comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Kras, prehrambena | XXX | XXX | XXX | XXX | XXX | XXX |
| LASCO Manufacturing | XXX | XXX | XXX | XXX | XXX | XXX |
| Duncan Fox | XXX | XXX | XXX | XXX | XXX | XXX |
| Rokiskio Suris | XXX | XXX | XXX | XXX | XXX | XXX |
| Naturhouse Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Treatt | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Kras, prehrambena M&A Activity
Kras, prehrambena acquired XXX companies to date.
Last acquisition by Kras, prehrambena was on XXXXXXXX, XXXXX. Kras, prehrambena acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Kras, prehrambena
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialKras, prehrambena Investment Activity
Kras, prehrambena invested in XXX companies to date.
Kras, prehrambena made its latest investment on XXXXXXXX, XXXXX. Kras, prehrambena invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Kras, prehrambena
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Kras, prehrambena
| When was Kras, prehrambena founded? | Kras, prehrambena was founded in 1911. |
| Where is Kras, prehrambena headquartered? | Kras, prehrambena is headquartered in Croatia. |
| How many employees does Kras, prehrambena have? | As of today, Kras, prehrambena has over 2K employees. |
| Is Kras, prehrambena publicly listed? | Yes, Kras, prehrambena is a public company listed on Zagreb Stock Exchange. |
| What is the stock symbol of Kras, prehrambena? | Kras, prehrambena trades under KRAS ticker. |
| Who are competitors of Kras, prehrambena? | Kras, prehrambena main competitors are LASCO Manufacturing, Duncan Fox, Rokiskio Suris, Naturhouse Health. |
| What is the current market cap of Kras, prehrambena? | Kras, prehrambena's current market cap is $176M. |
| What is the current revenue of Kras, prehrambena? | Kras, prehrambena's last fiscal year revenue is $229M. |
| What is the current EV/Revenue multiple of Kras, prehrambena? | Current revenue multiple of Kras, prehrambena is 0.8x. |
| Is Kras, prehrambena profitable? | No, Kras, prehrambena is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.